Access to insulin delivery devices and glycated haemoglobin in lower-income countries

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 8

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Aug 15, 2020; 11(8): 358-369
Published online Aug 15, 2020. doi: 10.4239/wjd.v11.i8.358

Table 7 Main challenges in providing glycated haemoglobin testing

Challenge	Number (%) of centres reporting this challenge
Cartridge cost	23 (70.9)
Stockouts	22 (68.8)
Maintenance of testing machine	21 (65.6)
Machine cost	18 (56.3)
Adequate supplies	15 (46.9)
Trained staff	15 (46.9)
Refrigeration	11 (34.4)
Adequate oversight of supplies	9 (28.1)
Other challenges	8 (25.0)

Citation: Klatman EL, Ogle GD. Access to insulin delivery devices and glycated haemoglobin in lower-income countries. World J Diabetes 2020; 11(8): 358-369
URL: https://www.wjgnet.com/1948-9358/full/v11/i8/358.htm
DOI: https://dx.doi.org/10.4239/wjd.v11.i8.358

Klatman EL, Ogle GD. Access to insulin delivery devices and glycated haemoglobin in lower-income countries. World J Diabetes 2020; 11(8): 358-369 [PMID: 32864048 DOI: 10.4239/wjd.v11.i8.358]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.